Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection.
Journal: Infectious diseases and therapy
Published: February 15, 2017
Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus Infection.
Journal: Clinical pharmacokinetics
Published: January 10, 2017
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study.
Journal: Hepatology international
Published: November 18, 2016
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.
Journal: Annals of hepatology
Published: October 15, 2016
Short-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study).
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 30, 2016
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 21, 2015
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1.
Journal: World journal of gastroenterology
Published: August 22, 2015
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence.
Journal: Hepatology (Baltimore, Md.)
Published: August 18, 2015
Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4).
Journal: Antiviral therapy
Published: August 16, 2015
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Journal: The New England journal of medicine
Published: July 22, 2015
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 08, 2015
Last Updated: 09/26/2026